Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Agrees To Acquire PCSK9 Base-Editing Partner Verve

17 Jun 2025

• By Joseph Haas

This is a picture of the Lilly building in San Diego — Lilly acquires base-editing partner Verve and its PCSK9 gene therapy (Shutterstock)

Related Companies

Eli Lilly and Company

Verve Therapeutics, Inc.

Amgen, Inc.

Regeneron Pharmaceuticals, Inc.

Novartis AG

AstraZeneca PLC

SiteOne Therapeutics, Inc.

Merck & Co., Inc.

Beam Therapeutics Inc.

Scorpion Therapeutics, Inc.

More from Gene Therapies

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.